Fangxia Wang

1.4k citations
40 papers · 894 · 1 hit paper · h-index 10

Impact in

  • Hematology top 5%
    • Multiple Myeloma Research and Treatments
  • Oncology top 5%
    • CAR-T cell therapy research

Papers in

    • Acute Myeloid Leukemia Research 9
    • Multiple Myeloma Research and Treatments 7
    • CAR-T cell therapy research 7
    • Neutropenia and Cancer Infections 3

Fangxia Wang

38 papers receiving 879 citations

Fangxia Wang's Hit Papers

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma 2018 · 443 citations
4430+2+5Years since publication100200300400

Peers

Fangxia Wang
Comparison fields: 5 of 69
  • Hematology 265
  • Oncology 562
  • Immunology 157
  • Molecular Biology 329
  • Radiology, Nuclear Medicine and Imaging 68
Replace Elizabeth Peguero with:
Elizabeth Peguero United States
Andrew A. Guirguis Australia
Maiko Matsushita Japan
Mahan Moshir Belgium
Sanil Bhatia Germany
Jais Rose Bjelke Denmark
Madhuwanti Srinivasan United States
Daniel Dirck Waller Canada
William Riordan United States
Fangxia Wang relative to Elizabeth Peguero United States Elizabeth Peguero's profile →
Citations per field
00.5×1.7×
Elizabeth Peguero · 1×
Citations per year

Countries citing papers authored by Fangxia Wang

Since Specialization
Citations

This map shows the geographic impact of Fangxia Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangxia Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangxia Wang more than expected).

Fields of papers citing papers by Fangxia Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangxia Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangxia Wang. The network helps show where Fangxia Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Fangxia Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fangxia Wang Line = papers co-authored together Fangxia Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma
Hit paper breakdown →
2018443
2 2022117
3 201984
4 200729
5 202027
6 201025
7 201920
8 202513
9 202212
10 202310
11 20259
12 20209
13 20238
14 20237
15 20237
16 20207
17 20166
18
Busulfan plus fludarabine compared with busulfan plus cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplantation in patients with hematologic neoplasms: a meta-analysis.
20155
19 20225
20 20225

About Fangxia Wang

Fangxia Wang is a scholar working on Hematology, Oncology, Geometry and Topology, Immunology and Computational Theory and Mathematics, having authored 40 papers that have together received 894 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (9 papers), CAR-T cell therapy research (7 papers), Multiple Myeloma Research and Treatments (7 papers), Graph theory and applications (6 papers), Immunotherapy and Immune Responses (3 papers), Neutropenia and Cancer Infections (3 papers), Plant Physiology and Cultivation Studies (2 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). The work is most often cited by research in Hematology (265 citations), Oncology (562 citations), Immunology (157 citations), Molecular Biology (329 citations) and Radiology, Nuclear Medicine and Imaging (68 citations). Fangxia Wang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Aili He, Ju Bai, Yinxia Chen, Wanhong Zhao, Baoyindureng Wu, Aili He, Liufang Gu, Xing-Mei Cao, Yun Yang and Bo Lei. Their work appears in journals such as match Communications in Mathematical and in Computer Chemistry, Journal of Hematology & Oncology, Sustainability, Aging and Clinical Proteomics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact